GPP
SAGE
Great Point Partners’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-269,010
| Closed | -$11.9M | – | 47 |
|
|
2021
Q3 | $11.9M | Buy |
269,010
+19,010
| +8% | +$842K | 2.78% | 16 |
|
|
2021
Q2 | $14.2M | Sell |
250,000
-132,085
| -35% | -$7.5M | 2.98% | 12 |
|
|
2021
Q1 | $28.6M | Sell |
382,085
-72,332
| -16% | -$5.41M | 5.91% | 4 |
|
|
2020
Q4 | $39.3M | Sell |
454,417
-1,512,271
| -77% | -$131M | 6.39% | 3 |
|
|
2020
Q3 | $120M | Sell |
1,966,688
-135,680
| -6% | -$8.29M | 10.81% | 2 |
|
|
2020
Q2 | $87.4M | Buy |
2,102,368
+277,889
| +15% | +$11.6M | 6.99% | 5 |
|
|
2020
Q1 | $52.4M | Buy |
1,824,479
+1,028,422
| +129% | +$29.5M | 5.47% | 7 |
|
|
2019
Q4 | $57.5M | Buy |
+796,057
| New | +$57.5M | 5% | 6 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 40 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 37 |
|
|
2018
Q1 | – | Sell |
-200,000
| Closed | -$32.9M | – | 37 |
|
|
2017
Q4 | $32.9M | Buy |
200,000
+90,500
| +83% | +$14.9M | 5.62% | 4 |
|
|
2017
Q3 | $6.82M | Sell |
109,500
-134,300
| -55% | -$8.37M | 1.33% | 19 |
|
|
2017
Q2 | $19.4M | Sell |
243,800
-58,009
| -19% | -$4.62M | 3.48% | 12 |
|
|
2017
Q1 | $21.5M | Sell |
301,809
-83,874
| -22% | -$5.96M | 4.26% | 10 |
|
|
2016
Q4 | $19.7M | Buy |
385,683
+120,790
| +46% | +$6.17M | 4.05% | 11 |
|
|
2016
Q3 | $12.2M | Sell |
264,893
-65,107
| -20% | -$3M | 3.11% | 14 |
|
|
2016
Q2 | $9.94M | Buy |
+330,000
| New | +$9.94M | 2.85% | 12 |
|